209 related articles for article (PubMed ID: 31732837)
21. The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells.
Boyle ST; Ingman WV; Poltavets V; Faulkner JW; Whitfield RJ; McColl SR; Kochetkova M
Oncogene; 2016 Jan; 35(1):105-15. PubMed ID: 25772241
[TBL] [Abstract][Full Text] [Related]
22. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis.
Kuhn NZ; Tuan RS
J Cell Physiol; 2010 Feb; 222(2):268-77. PubMed ID: 19847802
[TBL] [Abstract][Full Text] [Related]
23. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective.
Brisken C; Duss S
Stem Cell Rev; 2007 Jun; 3(2):147-56. PubMed ID: 17873347
[TBL] [Abstract][Full Text] [Related]
24. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.
Kaenel P; Antonijevic M; Richter S; Küchler S; Sutter N; Wotzkow C; Strange R; Andres AC
Int J Oncol; 2012 Feb; 40(2):357-69. PubMed ID: 22020958
[TBL] [Abstract][Full Text] [Related]
25. Influence of normal mammary epithelium on breast cancer progression: the protective role of early pregnancy.
Martins FC; Botelho MF; Cabrita AM; de Oliveira CF
Tumori; 2010; 96(6):999-1003. PubMed ID: 21388065
[TBL] [Abstract][Full Text] [Related]
26. Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture.
Briem E; Ingthorsson S; Traustadottir GA; Hilmarsdottir B; Gudjonsson T
J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):139-147. PubMed ID: 30684066
[TBL] [Abstract][Full Text] [Related]
27. Cancer Microenvironment: What Can We Learn from the Stem Cell Niche.
Lacina L; Plzak J; Kodet O; Szabo P; Chovanec M; Dvorankova B; Smetana K
Int J Mol Sci; 2015 Oct; 16(10):24094-110. PubMed ID: 26473842
[TBL] [Abstract][Full Text] [Related]
28. Cell plasticity in epithelial homeostasis and tumorigenesis.
Varga J; Greten FR
Nat Cell Biol; 2017 Oct; 19(10):1133-1141. PubMed ID: 28945230
[TBL] [Abstract][Full Text] [Related]
29. Microenvironmental control of the breast cancer cell cycle.
Guo X; Wu Y; Hathaway HJ; Hartley RS
Anat Rec (Hoboken); 2012 Apr; 295(4):553-62. PubMed ID: 22271550
[TBL] [Abstract][Full Text] [Related]
30. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers.
Sell S; Pierce GB
Lab Invest; 1994 Jan; 70(1):6-22. PubMed ID: 8302019
[TBL] [Abstract][Full Text] [Related]
31. Stem cells in human breast cancer.
Oliveira LR; Jeffrey SS; Ribeiro-Silva A
Histol Histopathol; 2010 Mar; 25(3):371-85. PubMed ID: 20054808
[TBL] [Abstract][Full Text] [Related]
32. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state.
Chaffer CL; Brueckmann I; Scheel C; Kaestli AJ; Wiggins PA; Rodrigues LO; Brooks M; Reinhardt F; Su Y; Polyak K; Arendt LM; Kuperwasser C; Bierie B; Weinberg RA
Proc Natl Acad Sci U S A; 2011 May; 108(19):7950-5. PubMed ID: 21498687
[TBL] [Abstract][Full Text] [Related]
33. The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate.
Boulanger CA; Bruno RD; Rosu-Myles M; Smith GH
Stem Cells Dev; 2012 Apr; 21(6):948-54. PubMed ID: 21649558
[TBL] [Abstract][Full Text] [Related]
34. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.
Liu S; Dontu G; Mantle ID; Patel S; Ahn NS; Jackson KW; Suri P; Wicha MS
Cancer Res; 2006 Jun; 66(12):6063-71. PubMed ID: 16778178
[TBL] [Abstract][Full Text] [Related]
35. Assays for functionally defined normal and malignant mammary stem cells.
Aalam SMM; Beer PA; Kannan N
Adv Cancer Res; 2019; 141():129-174. PubMed ID: 30691682
[TBL] [Abstract][Full Text] [Related]
36. Mammary epithelial reconstitution with gene-modified stem cells assigns roles to Stat5 in luminal alveolar cell fate decisions, differentiation, involution, and mammary tumor formation.
Vafaizadeh V; Klemmt P; Brendel C; Weber K; Doebele C; Britt K; Grez M; Fehse B; Desriviéres S; Groner B
Stem Cells; 2010 May; 28(5):928-38. PubMed ID: 20235097
[TBL] [Abstract][Full Text] [Related]
37. EMT in breast cancer stem cell generation.
Ansieau S
Cancer Lett; 2013 Sep; 338(1):63-8. PubMed ID: 22634497
[TBL] [Abstract][Full Text] [Related]
38. Role of microRNA221 in regulating normal mammary epithelial hierarchy and breast cancer stem-like cells.
Ke J; Zhao Z; Hong SH; Bai S; He Z; Malik F; Xu J; Zhou L; Chen W; Martin-Trevino R; Wu X; Lan P; Yi Y; Ginestier C; Ibarra I; Shang L; McDermott S; Luther T; Clouthier SG; Wicha MS; Liu S
Oncotarget; 2015 Feb; 6(6):3709-21. PubMed ID: 25686829
[TBL] [Abstract][Full Text] [Related]
39. Techniques for the Reprogramming of Exogenous Stem/Progenitor Cell Populations Towards a Mammary Epithelial Cell Fate.
Smith GH; Boulanger CA
Methods Mol Biol; 2017; 1501():277-289. PubMed ID: 27796959
[TBL] [Abstract][Full Text] [Related]
40. Plasticity of mammary epithelia during normal development and neoplastic progression.
Lochter A
Biochem Cell Biol; 1998; 76(6):997-1008. PubMed ID: 10392711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
